MYXOID/ROUND CELL LIPOSARCOMA
Clinical trials for MYXOID/ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOID/ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for MYXOID/ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cell therapy targets Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a new treatment called BOXR1030, which uses specially engineered immune cells to attack cancer cells that have a protein called GPC3. The study includes adults with advanced liver, lung, skin, or soft-tissue cancers that have not responded to other tr…
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Sotio Biotech Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a personalized cell therapy for people with certain cancers (bladder, melanoma, head/neck, ovarian, lung, esophageal, stomach, or sarcoma). The therapy takes a patient's own immune cells and genetically equips them to recognize and attack tumors that …
Matched conditions: MYXOID/ROUND CELL LIPOSARCOMA
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated May 20, 2026 11:55 UTC